Use of erythropoietic stimulating agents in the setting of renal disease
- 1 January 2009
- book chapter
- Published by Springer Nature
- p. 225-248
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- History-Adjusted Marginal Structural Analysis of the Association between Hemoglobin Variability and Mortality among Chronic Hemodialysis PatientsClinical Journal of the American Society of Nephrology, 2008
- Biosimilar Epoetins: Potential for Variation Reinforces Need for RegulationNephrology Times, 2008
- Hemoglobin Level VariabilityClinical Journal of the American Society of Nephrology, 2008
- Correction of Anemia with Epoetin Alfa in Chronic Kidney DiseaseNew England Journal of Medicine, 2006
- The Dialysis Outcomes and Practice Patterns Study (DOPPS): An international hemodialysis studyKidney International, 2000
- Changes in left ventricular size, wall thickness, and function in anemic patients treated with recombinant human erythropoietinAmerican Heart Journal, 1992
- Treatment with recombinant human erythropoietin increases antibody titers after hepatitis B vaccination in dialysis patientsKidney International, 1991
- Effect of Recombinant Human Erythropoietin on Anterior Pituitary Function in Patients on Chronic HemodialysisHormone Research, 1991
- Role of anemia in the pathogenesis of left ventricular hypertrophy in end-stage renal diseaseThe American Journal of Cardiology, 1989
- Hemodynamics of Uremic AnemiaCirculation, 1971